Fear of cancer may have unwanted effect on public screening uptake
the ONA take:
People who worry about developing cancer are more likely to want to undergo screening for colon cancer; however, according to new research from the Cancer Research UK Health Behaviour Research Centre at UCL, that fear makes them less likely to actually go for the test.
Research to date has used a combined measure of cancer fear, which does not explain how fear results in such different actions. In this study, the researchers distinguished different aspects of fear to see whether it had different effects on people’s decisions about cancer screening.
Approximately 2,000 participants were randomized to receive a screening invitation. Clinical records show that 71% actually attended; 68% of those who reported feeling uncomfortable thinking about cancer attended screening, compared with 77% of those who did not feel uncomfortable.
The research findings suggest that public service announcements about colon cancer screening need to focus more on the preventive value of screening than increasing public fear of cancer.
People who worry about developing cancer are more likely to want to undergo screening for colon cancer.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|